Cargando…

Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer’s Disease?

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that accounts for more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of AD disproportionately affect women, comprising two thirds of all AD cases. Although the underlying mechanisms for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Zoe B., Faull, Richard L. M., Kwakowsky, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964432/ https://www.ncbi.nlm.nih.gov/pubmed/36834617 http://dx.doi.org/10.3390/ijms24043205

Ejemplares similares

Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer’s disease
por: Kwakowsky, Andrea, et al.
Publicado: (2021)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review
por: Wood, Oliver W. G., et al.
Publicado: (2022)

Neuroprotective Effect of Caffeine in Alzheimer’s Disease
por: M Yelanchezian, Y Mukish, et al.
Publicado: (2022)

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease
por: Kwakowsky, Andrea, et al.
Publicado: (2016)

iGluR expression in the hippocampal formation, entorhinal cortex, and superior temporal gyrus in Alzheimer’s disease
por: Yeung, Jason HY, et al.
Publicado: (2022)

Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus
por: Govindpani, Karan, et al.
Publicado: (2020)

Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
por: Govindpani, Karan, et al.
Publicado: (2017)

Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway
por: Kwakowsky, Andrea, et al.
Publicado: (2018)

Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders
por: Lam, Patricia, et al.
Publicado: (2023)

Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?
por: Wood, Oliver WG, et al.
Publicado: (2023)

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
por: Govindpani, Karan, et al.
Publicado: (2019)

Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression
por: Kwakowsky, Andrea, et al.
Publicado: (2020)

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

Current Therapeutic Options for Alzheimer’s Disease
por: Lleó, Alberto
Publicado: (2007)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Hormone Replacement Therapy and Risk for Neurodegenerative Diseases
por: Dye, Richelin V., et al.
Publicado: (2012)

Newer therapeutic options for inherited retinal diseases: Gene and cell replacement therapy
por: Battu, Rajani, et al.
Publicado: (2022)

Metabotropic glutamate receptor 1 alpha: a unique receptor variant with variable implications for Alzheimer’s disease pathogenesis
por: Yeung, Jason HY, et al.
Publicado: (2023)

mGluR1α expression in the hippocampus, subiculum, entorhinal cortex and superior temporal gyrus in Alzheimer’s disease
por: Yeung, J.H.Y., et al.
Publicado: (2022)

Options of Renal Replacement Therapy in CKDu
por: Varughese, Santosh, et al.
Publicado: (2020)

Non-Pharmacological Therapeutic Options for the Treatment of Alzheimer’s Disease
por: Huynh, Quy-Susan, et al.
Publicado: (2022)

Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies: Hormone replacement therapy and lung cancer risk
por: Jin, Chao, et al.
Publicado: (2019)

Hormone replacement therapy and risk of epithelial ovarian cancer
por: Purdie, D M, et al.
Publicado: (1999)

Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas
por: Lindblad, M, et al.
Publicado: (2006)

GABA(A) Receptors Are Well Preserved in the Hippocampus of Aged Mice
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Enzyme replacement therapies: what is the best option?
por: Safary, Azam, et al.
Publicado: (2018)

Systematic identification of risk factors and drug repurposing options for Alzheimer's disease
por: Wu, Chong, et al.
Publicado: (2021)

A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause
por: Madsen, Tracy E, et al.
Publicado: (2023)

Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
por: Agarwal, Mugdha, et al.
Publicado: (2020)

Renal replacement therapy as a therapeutic option for right heart failure in severe pulmonary arterial hypertension
por: Shimbo, Mai, et al.
Publicado: (2022)

Sex- and age-related changes in GABA signaling components in the human cortex
por: Pandya, Madhavi, et al.
Publicado: (2019)

Risk factors for thyroid hormone replacement therapy after hemithyroidectomy and development of a predictive nomogram
por: Cao, Zhen, et al.
Publicado: (2022)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Emerging options in growth hormone therapy: an update
por: Kemp, Stephen F, et al.
Publicado: (2011)

Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer.
por: Fernandez, E., et al.
Publicado: (1996)

A Cost Analysis of Kidney Replacement Therapy Options in Palestine
por: Younis, Mustafa, et al.
Publicado: (2015)

Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?
por: Imbimbo, Bruno P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_urgitrkf62784mrskiahcpjva3